Literature DB >> 23603326

The relationship between red blood cell deformability metrics and perfusion of an artificial microvascular network.

Jose M Sosa1, Nathan D Nielsen2, Seth M Vignes1, Tanya G Chen1, Sergey S Shevkoplyas1.   

Abstract

The ability of red blood cells (RBC) to undergo a wide range of deformations while traversing the microvasculature is crucial for adequate perfusion. Interpretation of RBC deformability measurements performed in vitro in the context of microvascular perfusion has been notoriously difficult. This study compares the measurements of RBC deformability performed using micropore filtration and ektacytometry with the RBC ability to perfuse an artificial microvascular network (AMVN). Human RBCs were collected from healthy consenting volunteers, leukoreduced, washed and exposed to graded concentrations (0-0.08%) of glutaraldehyde (a non-specific protein cross-linker) and diamide (a spectrin-specific protein cross-linker) to impair the deformability of RBCs. Samples comprising cells with two different levels of deformability were created by adding non-deformable RBCs (hardened by exposure to 0.08% glutaraldehyde) to the sample of normal healthy RBCs. Ektacytometry indicated a nearly linear decline in RBC deformability with increasing glutaraldehyde concentration. Micropore filtration showed a significant reduction only for concentrations of glutaraldehyde higher than 0.04%. Neither micropore filtration nor ektacytometry measurements could accurately predict the AMVN perfusion. Treatment with diamide reduced RBC deformability as indicated by ektacytometry, but had no significant effect on either micropore filtration or the AMVN perfusion. Both micropore filtration and ektacytometry showed a linear decline in effective RBC deformability with increasing fraction of non-deformable RBCs in the sample. The corresponding decline in the AMVN perfusion plateaued above 50%, reflecting the innate ability of blood flow in the microvasculature to bypass occluded capillaries. Our results suggest that in vitro measurements of RBC deformability performed using either micropore filtration or ektacytometry may not represent the ability of same RBCs to perfuse microvascular networks. Further development of biomimetic tools for measuring RBC deformability (e.g. the AMVN) could enable a more functionally relevant testing of RBC mechanical properties.

Entities:  

Keywords:  Red blood cell deformability; artificial microvascular network; ektacytometry; microfluidics; micropore filtration

Mesh:

Substances:

Year:  2014        PMID: 23603326      PMCID: PMC3766416          DOI: 10.3233/CH-131719

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  67 in total

1.  Assessment of erythrocyte deformability with the laser-assisted optical rotational cell analyzer (LORCA).

Authors:  P Izzo; A Spagnuolo; A Manicone
Journal:  Boll Soc Ital Biol Sper       Date:  1999 Jan-Feb

2.  Artificial microvascular network: a new tool for measuring rheologic properties of stored red blood cells.

Authors:  Jennie M Burns; Xiaoxi Yang; Omid Forouzan; Jose M Sosa; Sergey S Shevkoplyas
Journal:  Transfusion       Date:  2011-11-02       Impact factor: 3.157

3.  Spontaneous oscillations of capillary blood flow in artificial microvascular networks.

Authors:  Omid Forouzan; Xiaoxi Yang; Jose M Sosa; Jennie M Burns; Sergey S Shevkoplyas
Journal:  Microvasc Res       Date:  2012-06-23       Impact factor: 3.514

4.  Laser diffractometry technique: clinical applications to vascular pathologies.

Authors:  Bibiana Riquelme; Patricia Foresto; Mabel D'Arrigo; Fernando Filippini; Juana Valverde
Journal:  Clin Hemorheol Microcirc       Date:  2006       Impact factor: 2.375

5.  Pulse shape analysis of RBC micropore flow via new software for the cell transit analyser (CTA).

Authors:  T C Fisher; R B Wenby; H J Meiselman
Journal:  Biorheology       Date:  1992 Mar-Jun       Impact factor: 1.875

6.  Erythrocyte spectrin maintains its segmental motions on oxidation: a spin-label EPR study.

Authors:  L W Fung; B O Kalaw; R M Hatfield; M N Dias
Journal:  Biophys J       Date:  1996-02       Impact factor: 4.033

7.  The relationship of packed cell transfusion to red blood cell deformability in systemic inflammatory response syndrome patients.

Authors:  M H Friedlander; R Simon; G W Machiedo
Journal:  Shock       Date:  1998-02       Impact factor: 3.454

8.  Effect of erythrocyte deformability on in vivo red cell transit time and hematocrit and their correlation with in vitro filterability.

Authors:  H H Lipowsky; L E Cram; W Justice; M J Eppihimer
Journal:  Microvasc Res       Date:  1993-07       Impact factor: 3.514

Review 9.  The clinical significance of whole blood viscosity in (cardio)vascular medicine.

Authors:  G A M Pop; D J Duncker; M Gardien; P Vranckx; S Versluis; D Hasan; C J Slager
Journal:  Neth Heart J       Date:  2002-12       Impact factor: 2.380

10.  Early alterations of red blood cell rheology in critically ill patients.

Authors:  Giulia Reggiori; Giovanna Occhipinti; Andrea De Gasperi; Jean-Louis Vincent; Michael Piagnerelli
Journal:  Crit Care Med       Date:  2009-12       Impact factor: 7.598

View more
  30 in total

1.  Deterioration of red blood cell mechanical properties is reduced in anaerobic storage.

Authors:  Jennie M Burns; Tatsuro Yoshida; Larry J Dumont; Xiaoxi Yang; Nathaniel Z Piety; Sergey S Shevkoplyas
Journal:  Blood Transfus       Date:  2015-11-27       Impact factor: 3.443

2.  Effect of osmolality on erythrocyte rheology and perfusion of an artificial microvascular network.

Authors:  Walter H Reinhart; Nathaniel Z Piety; Jeroen S Goede; Sergey S Shevkoplyas
Journal:  Microvasc Res       Date:  2015-02-07       Impact factor: 3.514

3.  Differential dielectroscopic data on the relation of erythrocyte membrane skeleton to erythrocyte deformability and flicker.

Authors:  Ivan T Ivanov; Boyana K Paarvanova
Journal:  Eur Biophys J       Date:  2021-01-13       Impact factor: 1.733

4.  High-throughput microsphiltration to assess red blood cell deformability and screen for malaria transmission-blocking drugs.

Authors:  Julien Duez; Mario Carucci; Irene Garcia-Barbazan; Matias Corral; Oscar Perez; Jesus Luis Presa; Benoit Henry; Camille Roussel; Papa Alioune Ndour; Noemi Bahamontes Rosa; Laura Sanz; Francisco-Javier Gamo; Pierre Buffet
Journal:  Nat Protoc       Date:  2018-05-24       Impact factor: 13.491

5.  Influence of feeding hematocrit and perfusion pressure on hematocrit reduction (Fåhraeus effect) in an artificial microvascular network.

Authors:  Walter H Reinhart; Nathaniel Z Piety; Sergey S Shevkoplyas
Journal:  Microcirculation       Date:  2017-11       Impact factor: 2.628

6.  Microfluidic assessment of red blood cell mediated microvascular occlusion.

Authors:  Yuncheng Man; Erdem Kucukal; Ran An; Quentin D Watson; Jürgen Bosch; Peter A Zimmerman; Jane A Little; Umut A Gurkan
Journal:  Lab Chip       Date:  2020-05-19       Impact factor: 6.799

Review 7.  Blood rheology biomarkers in sickle cell disease.

Authors:  Madeleine Lu; Minke Ae Rab; Sergey S Shevkoplyas; Vivien A Sheehan
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-16

8.  Shape matters: the effect of red blood cell shape on perfusion of an artificial microvascular network.

Authors:  Nathaniel Z Piety; Walter H Reinhart; Patrick H Pourreau; Rajaa Abidi; Sergey S Shevkoplyas
Journal:  Transfusion       Date:  2015-12-29       Impact factor: 3.157

9.  Washing stored red blood cells in an albumin solution improves their morphologic and hemorheologic properties.

Authors:  Walter H Reinhart; Nathaniel Z Piety; Jeremy W Deuel; Asya Makhro; Thomas Schulzki; Nikolay Bogdanov; Jeroen S Goede; Anna Bogdanova; Rajaa Abidi; Sergey S Shevkoplyas
Journal:  Transfusion       Date:  2015-03-06       Impact factor: 3.157

Review 10.  Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrier.

Authors:  Carlos H Villa; Daniel C Pan; Sergei Zaitsev; Douglas B Cines; Donald L Siegel; Vladimir R Muzykantov
Journal:  Ther Deliv       Date:  2015-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.